Invention Grant
- Patent Title: Modified polymerases for improved incorporation of nucleotide analogues
-
Application No.: US16018691Application Date: 2018-06-26
-
Publication No.: US11136564B2Publication Date: 2021-10-05
- Inventor: Geoffrey Paul Smith , David Mark Dunstan Bailey , Raquel Maria Sanches-Kuiper , Harold Swerdlow , David James Earnshaw
- Applicant: Illumina Cambridge Limited
- Applicant Address: GB Nr Saffron Walden
- Assignee: Illumina Cambridge Limited
- Current Assignee: Illumina Cambridge Limited
- Current Assignee Address: GB Nr Saffron Walden
- Agency: Mueting Raasch Group
- Priority: GB0321306 20030911
- Main IPC: C12N9/12
- IPC: C12N9/12 ; C12Q1/6869

Abstract:
The invention relates to modified polymerase enzymes which exhibit improved incorporation of nucleotide analogues bearing substituents at the 3′ position of the sugar moiety that are larger in size than the naturally occurring 3′ hydroxyl group. Also described are methods of using the polymerases to incorporate nucleotides into polynucleotides, particularly in the context of DNA sequencing.
Public/Granted literature
- US20180298358A1 MODIFIED POLYMERASES FOR IMPROVED INCORPORATION OF NUCLEOTIDE ANALOGUES Public/Granted day:2018-10-18
Information query